geniposide has been researched along with Insulin Resistance in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fan, M; Li, Y; Liu, J; Nie, C; Qian, H; Song, C; Sun, Y; Wang, L; Wang, Y; Xue, L | 1 |
Pu, M; Shen, S; Yin, F; Zhao, W | 1 |
Jiang, H; Li, L; Liu, J; Ma, Y; Yan, J | 1 |
Aburada, M; Ishizaki, J; Kojima, K; Miyamoto, K; Nagareda, Y; Sai, Y; Shimada, T; Watanabe, M | 1 |
4 other study(ies) available for geniposide and Insulin Resistance
Article | Year |
---|---|
A novel regulatory mechanism of geniposide for improving glucose homeostasis mediated by circulating RBP4.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Glucose; Homeostasis; Insulin; Insulin Resistance; Iridoids; Liver; Mice; Mice, Inbred C57BL; Retinol-Binding Proteins, Plasma | 2022 |
Geniposide improves insulin resistance through AMPK-mediated Txnip protein degradation in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Enzyme Activation; Insulin Resistance; Iridoids; Mice; Proteolysis; Signal Transduction; Thioredoxins | 2021 |
Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF‑κB/GLUT‑4.
Topics: Autophagy; Glucose Transporter Type 4; Hep G2 Cells; Humans; Insulin Resistance; Iridoids; Microscopy, Confocal; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Models, Biological; NF-kappa B; Sequestosome-1 Protein; Signal Transduction; Sirolimus | 2017 |
Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fatty Acids, Nonesterified; Fatty Liver; Gardenia; Glucose Intolerance; Hep G2 Cells; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iridoids; Lipid Metabolism; Liver; Male; Metabolic Diseases; Metabolic Syndrome; Mice; Mice, Obese; Obesity; Phytotherapy; Plant Preparations | 2011 |